World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
61
Citations
14343
World Ranking
3662
National Ranking
328

Overview

Richard Appleton is affiliated with Alder Hey Children's Hospital in the United Kingdom and has contributed extensively to the field of medicine, with a focus on pediatrics, perinatology, and child health. Their research primarily centers on epilepsy research and treatment, pharmacological effects and toxicity studies, and related topics including hemoglobinopathies, neonatal and fetal brain pathology, ethics in clinical research, pharmaceutical studies and practices, and drug transport and resistance mechanisms.

Appleton's body of work includes significant contributions to epilepsy treatment and emergency medical protocols for children. Their recent publications cover clinical trials and reviews related to epilepsy drugs and emergency treatments:

  • The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial (2021) - The Lancet
  • The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial (2021) - The Lancet
  • Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs (2021) - Health Technology Assessment
  • Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT (2020) - Health Technology Assessment
  • Optimal Management of Status Epilepticus in Children in the Emergency Setting: A Review of Recent Advances (2022) - Open Access Emergency Medicine

Appleton has frequently published in well-known venues such as The Lancet, Health Technology Assessment, Emergency Medicine Journal, Open Access Emergency Medicine, and Archives of Disease in Childhood Education & Practice.

Collaboration appears as a significant component of their work, with frequent co-authors including Richard Brown, Stephen Howell, Melissa Maguire, Anthony G Marson, and Girvan Burnside.

Best Publications

  • The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.

    Anthony G Marson;Asya M Al-Kharusi;Muna Alwaidh;Richard Appleton

  • The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

    Anthony G Marson;Asya M Al-Kharusi;Muna Alwaidh;Richard Appleton

  • Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial.

    John McIntyre;Sue Robertson;Elizabeth Norris;Richard Appleton

  • Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.

    Orrin Devinsky;Anup D. Patel;Elizabeth A. Thiele;Matthew H. Wong

  • Febrile seizures: an update

    C Waruiru;R Appleton

  • THE TREATMENT OF SLEEP DISORDERS WITH MELATONIN

    J E Jan;H Espezel;R E Appleton

  • Randomised, Placebo‐Controlled Study of Vigabatrin as First‐Line Treatment of Infantile Spasms

    R. E. Appleton;A. C. B. Peters;J. P. Mumford;D. E. Shaw

  • Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children.

    Amy McTague;Timothy Martland;Richard Appleton

  • Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial.

    P Gringras;C Gamble;A P Jones;L Wiggs

  • Nonconvulsive status epilepticus: Epilepsy Research Foundation Workshop Reports

    Matthew Walker;Helen Cross;Shelagh Smith;Camilla Young

  • Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology

    Claudia B. Catarino;Joan Y.W. Liu;Ioannis Liagkouras;Vaneesha S. Gibbons

  • Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial

    Mark D. Lyttle;Mark D. Lyttle;Naomi E A. Rainford;Carrol. Gamble;Shrouk. Messahel

  • Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease

    Shahd H. M. Hamid;Dan Whittam;Mariyam Saviour;Amal Alorainy

  • The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies

    A Nicolson;R E Appleton;D W Chadwick;D F Smith

  • LORAZEPAM VERSUS DIAZEPAM IN THE ACUTE TREATMENT OF EPILEPTIC SEIZURES AND STATUS EPILEPTICUS

    R Appleton;A Sweeney;I Choonara;J Robson

  • The treatment of convulsive status epilepticus in children. The Status Epilepticus Working Party, Members of the Status Epilepticus Working Party.

    R Appleton;I Choonara;T Martland;B Phillips

  • Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies

    Haiyan Zhou;Heinz Jungbluth;Caroline A. Sewry;Lucy Feng

  • The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.

    Anthony Marson;Girvan Burnside;Richard Appleton;Dave Smith

  • A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica

    Anand Iyer;Liene Elsone;Richard Appleton;Anu Jacob

  • The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.

    Anthony Marson;Girvan Burnside;Richard Appleton;Dave Smith

  • Gabapentin as Add‐On Therapy in Children with Refractory Partial Seizures: A 12‐Week, Multicentre, Double‐Blind, Placebo‐Controlled Study

    Richard Appleton;Klaus Fichtner;Linda LaMoreaux;Jeannine Alexander

  • Best practice guidelines for the management of women with epilepsy

    P Crawford;R Appleton;T Betts;J Duncan

  • Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients

    Liene Elsone;Jay Panicker;Kerry Mutch;Mike Boggild

  • Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum.

    Amy McTague;Amy McTague;Richard Appleton;Shivaram Avula;J. Helen Cross;J. Helen Cross

Frequent Co-Authors

Anthony G Marson
Anthony G Marson University of Liverpool
Gus A. Baker
Gus A. Baker University of Liverpool
Peter Camfield
Peter Camfield Dalhousie University
Graeme J. Sills
Graeme J. Sills University of Glasgow
J. Helen Cross
J. Helen Cross Great Ormond Street Hospital
Manju A. Kurian
Manju A. Kurian University College London
Roderick Duncan
Roderick Duncan Christchurch Hospital
Ingrid E. Scheffer
Ingrid E. Scheffer University of Melbourne
Josemir W. Sander
Josemir W. Sander University College London
John M. Pellock
John M. Pellock Virginia Commonwealth University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Richard Appleton

Trending Scientists